Kevin Fischbeck
Stock Analyst at B of A Securities
(3.98)
# 613
Out of 5,042 analysts
186
Total ratings
64.62%
Success rate
6.05%
Average return
Main Sectors:
Stocks Rated by Kevin Fischbeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUM Humana | Maintains: Neutral | $280 → $300 | $290.65 | +3.22% | 17 | Oct 10, 2025 | |
| ELV Elevance Health | Maintains: Neutral | $330 → $370 | $342.35 | +8.08% | 4 | Oct 10, 2025 | |
| UNH UnitedHealth Group | Maintains: Neutral | $350 → $390 | $362.50 | +7.59% | 27 | Oct 8, 2025 | |
| AMN AMN Healthcare Services | Maintains: Underperform | $20 → $18 | $21.17 | -14.97% | 5 | Sep 10, 2025 | |
| DVA DaVita | Maintains: Underperform | $145 → $140 | $129.19 | +8.37% | 13 | Sep 10, 2025 | |
| THC Tenet Healthcare | Maintains: Buy | $205 → $225 | $210.38 | +6.95% | 7 | Sep 10, 2025 | |
| EHC Encompass Health | Maintains: Buy | $145 → $160 | $126.13 | +26.85% | 2 | Sep 10, 2025 | |
| ARDT Ardent Health | Downgrades: Underperform | $16 → $15 | $15.21 | -4.01% | 3 | Jul 16, 2025 | |
| CNC Centene | Downgrades: Underperform | $52 → $30 | $34.07 | -11.95% | 13 | Jul 16, 2025 | |
| UHS Universal Health Services | Downgrades: Underperform | $215 → $185 | $210.68 | -12.19% | 15 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $394 → $410 | $447.04 | -8.29% | 11 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $33 | $23.39 | +41.12% | 8 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $3 | $0.97 | +209.31% | 2 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $439 | $163.32 | +168.80% | 15 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $6.5 | $9.37 | -30.63% | 2 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.25 | $17.51 | -58.60% | 3 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $350 | $301.78 | +15.98% | 6 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $42 → $45 | $22.80 | +97.37% | 7 | Jun 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.5 → $5.5 | $4.10 | +34.15% | 10 | Jun 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $14.29 | +144.93% | 7 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $10 | $3.82 | +161.78% | 2 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7.5 | $12.96 | -42.13% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $27.91 | -35.51% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $17.60 | - | 3 | Sep 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $19 | $28.54 | -33.43% | 2 | Feb 9, 2018 |
Humana
Oct 10, 2025
Maintains: Neutral
Price Target: $280 → $300
Current: $290.65
Upside: +3.22%
Elevance Health
Oct 10, 2025
Maintains: Neutral
Price Target: $330 → $370
Current: $342.35
Upside: +8.08%
UnitedHealth Group
Oct 8, 2025
Maintains: Neutral
Price Target: $350 → $390
Current: $362.50
Upside: +7.59%
AMN Healthcare Services
Sep 10, 2025
Maintains: Underperform
Price Target: $20 → $18
Current: $21.17
Upside: -14.97%
DaVita
Sep 10, 2025
Maintains: Underperform
Price Target: $145 → $140
Current: $129.19
Upside: +8.37%
Tenet Healthcare
Sep 10, 2025
Maintains: Buy
Price Target: $205 → $225
Current: $210.38
Upside: +6.95%
Encompass Health
Sep 10, 2025
Maintains: Buy
Price Target: $145 → $160
Current: $126.13
Upside: +26.85%
Ardent Health
Jul 16, 2025
Downgrades: Underperform
Price Target: $16 → $15
Current: $15.21
Upside: -4.01%
Centene
Jul 16, 2025
Downgrades: Underperform
Price Target: $52 → $30
Current: $34.07
Upside: -11.95%
Universal Health Services
Jul 16, 2025
Downgrades: Underperform
Price Target: $215 → $185
Current: $210.68
Upside: -12.19%
Jul 16, 2025
Downgrades: Neutral
Price Target: $394 → $410
Current: $447.04
Upside: -8.29%
May 13, 2025
Maintains: Buy
Price Target: $40 → $33
Current: $23.39
Upside: +41.12%
Oct 2, 2024
Downgrades: Underperform
Price Target: $3
Current: $0.97
Upside: +209.31%
Apr 1, 2024
Downgrades: Underperform
Price Target: $439
Current: $163.32
Upside: +168.80%
Nov 8, 2023
Downgrades: Underperform
Price Target: $6.5
Current: $9.37
Upside: -30.63%
Nov 2, 2023
Downgrades: Neutral
Price Target: $7.25
Current: $17.51
Upside: -58.60%
Aug 4, 2023
Maintains: Buy
Price Target: $320 → $350
Current: $301.78
Upside: +15.98%
Jun 2, 2023
Upgrades: Buy
Price Target: $42 → $45
Current: $22.80
Upside: +97.37%
Jun 15, 2022
Downgrades: Neutral
Price Target: $7.5 → $5.5
Current: $4.10
Upside: +34.15%
Jan 18, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $14.29
Upside: +144.93%
Jun 10, 2021
Downgrades: Underperform
Price Target: $10
Current: $3.82
Upside: +161.78%
Oct 8, 2020
Initiates: Underperform
Price Target: $7.5
Current: $12.96
Upside: -42.13%
Jun 24, 2020
Initiates: Buy
Price Target: $18
Current: $27.91
Upside: -35.51%
Sep 6, 2019
Downgrades: Underperform
Price Target: n/a
Current: $17.60
Upside: -
Feb 9, 2018
Maintains: Buy
Price Target: $23 → $19
Current: $28.54
Upside: -33.43%